June 4, 2020

The Niche

Knoepfler lab stem cell blog

Lung Institute

5 min read

Washington Post reporters William Wan and Laurie McGinley have a new piece on the unproven regenerative clinic firm the Lung Health Institute. This article has a number of surprises and new insights. Previously the Lung Health Institute was called just the Lung Institute. It was recently acquired by the publicly-traded company H-CYTE, stock symbol HCYT. In the past they marketed stem cells for various pulmonary diseases included COPD. Now it appears they are primarily marketing a form of platelet-rich plasma (PRP), which the company claims in …Read More

4 min read

Who decides whether a stem cell therapy is “good” or “bad”, and should that kind of a judgment be more focused on direct patient perspectives such as their stem cell therapy reviews as consumers or based on biomedical science? Both? I’ve written before about how stem cell patients are increasingly thinking of themselves as consumers and posting stem cell therapy reviews online including on more general consumer review sites such as Yelp. As much as one can find many positive and some negative overall …Read More

3 min read

Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions, which looks to be a dramatic year in the field of stem cells and regenerative medicine. The Score Card on 2016 Predictions Another stem cell biotech acquisition by pharma …Read More

4 min read

There is a growing trend of apparently unhappy patients suing stem cell clinics, which have faced more lawsuits recently and some of these cases are proposed class action suits that could have much broader impact. The latest case is against San Diego-based Stemgenex, a clinic that has claimed amongst other things that it can treat numerous diverse afflictions and that it has had a 100% customer satisfaction rate. KPBS reporter David Wagner also has more on this story. Wagner also noted that Stemgenex has publicly argued for less FDA oversight of …Read More